Though Boston Scientific has lagged behind the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Boston Scientific Corporation (NYSE:BSX) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds.

Penumbra is expected to give Boston Scientific more of a presence in the vascular surgery market, with little overlap between ...

What Happened? Shares of medical device company Boston Scientific (NYSE:BSX) fell 4.6% in the afternoon session after the company agreed to acquire Penumbra in a transaction valued at approximately ...

It is hard to get excited after looking at Boston Scientific's (NYSE:BSX) recent performance, when its stock has declined 10% ...

Shares of Boston Scientific Corp. BSX rose 1.30% to $93.53 Friday, on what proved to be an all-around dismal trading session ...

Boston Scientific BSX is slated to report fourth-quarter 2025 results on Feb. 4, before market open. The renowned medical device manufacturer posted earnings per share (EPS) of 75 cents in the last ...

Boston Scientific (BSX) on Thursday announced a definitive agreement to acquire Penumbra (PEN) in a cash and stock transaction that values the Alameda-based thrombectomy company at ~$14.5B.

Boston Scientific’s BSX second-quarter 2025 performance was driven by its robust expansion of operations across different geographies outside the United States. The company’s impressive growth within ...

Delving into the details, we found 47% of traders were bullish, while 47% showed bearish tendencies. Out of all the trades we ...